Laurus Labs Limited
LAURUSLABS
Rankning i aktier
#1747
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Aktiekurs
$22.83
Senast synkroniserad: 2026-10-19
Marknadsvärde
$12.34B
Förändring (1 dag)
0.51%
Förändring (1 år)
117.95%
Land
IN
Handel Laurus Labs Limited (LAURUSLABS)
Kategori
Healthcare
P/S-tal för Laurus Labs Limited (LAURUSLABS)
P/S-tal per October 2026 TTM: 15.12
Enligt Laurus Labs Limited senaste finansiella rapporter och aktiekurs är det aktuella P/S-talet (TTM) 15.12. I slutet av 2024 hade företaget ett P/S-tal på 4.35.
Historik för P/S-tal för Laurus Labs Limited från 2013 till 2026
P/S-tal vid årets slut
| År | P/S-tal | Ändra |
|---|---|---|
| 2026 (TTM) | 15.12 | 159.78% |
| 2025 | 5.82 | 33.90% |
| 2024 | 4.35 | 66.65% |
| 2023 | 2.61 | -59.76% |
| 2022 | 6.48 | 57.81% |
| 2021 | 4.11 | 226.89% |
| 2020 | 1.26 | -33.15% |
| 2019 | 1.88 | -30.33% |
| 2018 | 2.70 | 7.66% |
| 2017 | 2.50 | 13.66% |
| 2016 | 2.20 | -2.38% |
| 2015 | 2.26 | -11.20% |
| 2014 | 2.54 | -53.23% |
| 2013 | 5.44 | 0.00% |
P/S-tal för liknande företag eller konkurrenter
| Företag | P/S-tal | Skillnad i P/S-tal | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -53.32% |
IN
|
